Denmark Medical Cannabis: The Four Prescription Routes in 2026
Denmark medical cannabis is prescription-only through four routes. See who can prescribe each, what the pharmacy supplies, and how the 50% subsidy cap works.
Professor High
Written by Professor High, our AI guide. See how we research and correct articles.
In Denmark, every legal route to medical cannabis is a doctor’s prescription filled at a pharmacy, and there are four of them: authorised medicines, imported medicines on a special permit, pharmacy-made preparations, and a licensed-product scheme that became permanent on 1 January 2026. There is no medical cannabis card and no dispensary. The Danish Medicines Agency puts it in one line: you can get medical cannabis only if your doctor has prescribed it and you buy it from a pharmacy. Danish Medicines Agency, medical cannabis hub
Here is the line worth forwarding. Denmark’s “permanent” scheme is not a card or a shop. Any doctor may prescribe, a pharmacy makes the product to order, one prescription covers at most one month, and the state refunds 50% of the first 20,000 DKK a patient spends in a 12-month period. That caps the refund at 10,000 DKK a year. Subsidy order, BEK nr 1586
One warning. The agency’s English page still calls the scheme a pilot. The Danish pages, updated in 2026, describe the permanent scheme, and this guide follows them and the legal texts. It covers medical prescriptions only, not recreational law.
Laws, guidance and agency pages checked October 29, 2026.
What are the four ways to get medical cannabis in Denmark?
Denmark runs four prescription routes, and only one is “the cannabis scheme”. The government’s bill says the other three sit outside the scheme, under other law. Bill L 135 with explanatory notes
| Route | What the patient gets | Who prescribes | Who supplies it | Part of the scheme? |
|---|---|---|---|---|
| Authorised medicines | Sativex and Epidyolex | Specialist doctors only | Pharmacy | No |
| Unauthorised medicines on a permit | Cesamet (nabilone), Marinol or Syndros (dronabinol) | A doctor who applies for a dispensing permit (udleveringstilladelse) | Imported for the named patient, dispensed by a pharmacy | No |
| Magistral preparations | A preparation made for one patient | A doctor | Made by a pharmacy | No |
| The cannabis scheme | A “cannabis end product” made from an agency-listed intermediate product | Any doctor, with specialist recommendations for some conditions | Made by the pharmacy for each prescription | Yes |
The first three rows come from the agency’s hub page. Danish Medicines Agency Sativex is the medicine most readers know from MS spasticity; our guide to MS spasticity and spinal cord injury science covers what the trials show. Epidyolex is a purified CBD medicine; prescription CBD for epilepsy explains where that evidence came from.
The agency also warns about something that is not a route. “Cannabis oils” and “CBD oils” sold online as supplements with health claims are illegal medicines in Denmark. Danish Medicines Agency

On the cannabis scheme, the pharmacy makes each product to order from a listed intermediate product. One prescription covers at most one month.
What changed on 1 January 2026?
The scheme stopped being a trial. Parliament passed Act no. 439 of 6 May 2025, which replaces the word forsøgsordning (trial scheme) with ordning (scheme) and takes effect on 1 January 2026. Act no. 439 of 6 May 2025
The history is short:
- The trial scheme opened on 1 January 2018 and was first set to run to 2021. Bill L 135
- An amending act extended it to the end of 2025. Bill L 135
- On 28 November 2024, the government and a broad group of parties agreed to make it permanent. The ministry said about 1,800 patients a year had been prescribed medical cannabis and 20,000 prescriptions had been redeemed since 2018. Ministry press release, 28 November 2024
- The permanent scheme started on 1 January 2026. Danish Medicines Agency, the cannabis scheme
What did not change matters too. Cannabis stays a controlled substance, and the scheme stays a prescription system. The stated aim was patient safety: doctors prescribe instead of leaving patients to the illegal market. The subsidy “continues unchanged”. Bill L 135 That is a different design from Germany, which took cannabis off its narcotics law, and from the Netherlands, where the Dutch tolerate retail sale in coffeeshops.
Can any doctor prescribe medical cannabis in Denmark?
Yes, in law, but the guidance points some patients to specialists. Danish doctors have free prescribing rights, so they can prescribe scheme products beyond the listed conditions. No doctor has a duty to prescribe. Danish Medicines Agency, the cannabis scheme
The August 2026 guideline for doctors adds three layers. Guideline VEJ nr 9750 of 14 August 2026
- Pain: any doctor may prescribe.
- MS or spinal cord injury: the patient should be treated by a neurologist.
- Nausea from chemotherapy: the patient should be treated by a haematologist, an oncologist or a palliative-care hospital doctor.
“Should” (bør) is a recommendation, not a legal bar. The specialist-only rule is real for the two authorised medicines, Sativex and Epidyolex. Danish Medicines Agency
“May prescribe” also does not mean “will prescribe”. A national survey of Danish GPs in the scheme’s first year asked about this. Of those who answered, 8.7% had prescribed it, 80.6% said they knew little or nothing about it, and 71.4% viewed prescribing negatively. Only 38% of GPs answered, and views may have changed since. Rosenbæk et al., BMC Primary Care, 2023 If you want to raise it with your own doctor, our guide to talking to your doctor about cannabis helps you prepare.
What conditions does Denmark point to?
The agency lists five indications where it considers the scheme relevant. Danish Medicines Agency, the cannabis scheme
- Nerve pain (neuropathic pain)
- Pain from cancer
- Central nerve pain and painful spasticity in MS
- Pain after a spinal cord injury
- Nausea and vomiting from chemotherapy
For the research behind two of these, see cancer pain and chemotherapy nausea evidence and what the 2026 chronic-pain review found.
The same page says authorised medicines come first, and it clearly recommends against use under 18. The doctors’ guideline lists situations where treatment is contraindicated. They include schizophrenia (also in the family), other serious psychotic conditions, severe personality disorders, depression or a prior suicide attempt, severe liver or kidney impairment, and breastfeeding. It does not recommend the products in severe cardiovascular disease. Guideline VEJ nr 9750
What does a patient actually receive?
A scheme patient receives a product the pharmacy made for that prescription, not a packaged item off a shelf. By law, a pharmacy makes the end product only from an intermediate product on the agency’s list. It may sell only what it made itself. Act no. 439
The guideline sets the prescription rules. Guideline VEJ nr 9750
- One prescription covers at most one month of use.
- The doctor issues it electronically in the Shared Medicine Record (Fælles Medicinkort).
- It carries the patient’s name, address and CPR number.
- The pharmacy may dispense it once.
- The doctor records why treatment started and which conventional treatments the patient already tried.
The product range is not fixed. Manufacturers apply to have products listed, so the list changes, and the agency publishes the current one on medicinpriser.dk. Those products “are not authorised medicines, neither in Denmark nor in other countries”. They usually have not been tested in clinical trials, and they come without a package leaflet. Danish Medicines Agency, the cannabis scheme The guideline also discourages smoking.
How much does it cost, and what is the subsidy?
The subsidy covers half of a patient’s spending up to a cap, then nothing. The executive order in force since 1 January 2026 sets these rules. BEK nr 1586 of 5 December 2025
| Spending in a 12-month period | Share the region pays |
|---|---|
| First 20,000 DKK | 50% |
| Above 20,000 DKK | 0% |
| Patient with a terminal-care permit | 100% of the consumer price |
The 12-month period starts at the first purchase. The subsidy uses the agency’s published subsidy price and is tracked apart from ordinary medicine subsidy. The minister can adjust the limits twice a year, so check the current figures. Danish Medicines Agency, subsidy limits The subsidy is for people entitled to services under the Danish Health Act.
What does the Danish evidence show?
It shows a mixed signal from observational data, not a verdict. “Permanent” is a political decision about a prescribing system. The doctors’ guideline calls the evidence “limited and for many indications insufficient”. Guideline VEJ nr 9750
Four Danish studies are worth knowing, each with its limit stated.
- National register, pain patients. Pilot patients with nerve pain used less gabapentin and spent fewer days in hospital than matched controls. THC users used more opioids, and other pain types showed no benefit. The outcomes are drug and hospital records, not pain scores. Hjorthøj et al., European Journal of Pain, 2022
- Cross-sectional comparison. Patients were more satisfied with treatment and scored lower on depression than controls. They also reported more bodily pain and showed signs of worse MS symptoms. A snapshot like this cannot show cause and effect. Kudahl et al., Complementary Therapies in Clinical Practice, 2021
- One pain centre’s records. In adults with hard-to-treat chronic pain, 17% had a clinically relevant pain drop at the first follow-up and 10% at the second, counting everyone who started. Counting only those who stayed on treatment, the figures were 32% and 45%. Most people left before the second visit, so the two counts differ. Horsted et al., European Journal of Pain, 2023
- Heart rhythm. In chronic-pain patients starting prescribed cannabis, the 180-day risk of new-onset arrhythmia was 0.8% versus 0.4% in matched controls. The study found no clear link with acute coronary syndrome. The absolute risk is small, and the data are observational. Holt et al., European Heart Journal, 2024 Our guide to cannabis and heart rhythm puts that study in context.

Danish real-world studies observe patients after the fact. They can show patterns, both helpful and harmful, but they cannot prove that scheme products work.
On safety, the guideline counts 132 suspected adverse-reaction reports from 2018 to 2024, 16 of them serious. It found no new safety signal. Those are reports, not a rate of harm. Doctors must inform patients fully, report suspected reactions and assess driving risk. Guideline VEJ nr 9750 For the general picture, see driving after cannabis and how cannabis interacts with other medicines.
When to talk to a clinician: if you use cannabis for a health condition and notice a racing or irregular heartbeat, chest pain, new low mood, confusion or paranoia, contact a doctor promptly. Tell your doctor about every cannabis product you use, including anything bought outside a pharmacy. It changes what they can safely prescribe. This guide does not give treatment advice.
Can visitors or foreigners get medical cannabis in Denmark?
We found no official page that answers this directly. Here is what the official sources do say.
- The scheme prescription carries the patient’s CPR number, the Danish personal identification number. Guideline VEJ nr 9750
- The subsidy goes to people entitled to services under the Danish Health Act. BEK nr 1586
- Since 1 January 2026, the agency no longer reviews exemption applications from foreign nationals who need to bring medicine for longer stays. Danish Medicines Agency news, 11 December 2025
Bringing medicine in follows separate rules. Medicine with euphoriant substances may enter in up to 30 days’ supply for personal use, with proof of prescription. It may never arrive by post. The agency names medicinal cannabis in this category, and breaches go to the police. Danish Medicines Agency, importing euphoriant medicines Those pages do not say that a particular foreign product or prescription will be accepted at the border. Our guide to crossing borders with cannabis covers the wider travel risks.
Key takeaways
- Every legal route in Denmark is a doctor’s prescription filled at a pharmacy; there is no card and no dispensary.
- Four routes exist: authorised medicines, permit imports, magistral preparations and the cannabis scheme.
- The scheme became permanent on 1 January 2026; its products are not authorised medicines.
- Any doctor may prescribe on the scheme, but guidance points MS, spinal cord and chemotherapy patients to specialists.
- The subsidy is 50% of the first 20,000 DKK a year, at most 10,000 DKK, and the limits can change.
- Danish studies are observational and show both possible benefit and possible harm.
FAQ
Is medical cannabis legal in Denmark?
Yes, on a doctor’s prescription filled at a pharmacy. Denmark offers four prescription routes, including a cannabis scheme that became permanent on 1 January 2026. Cannabis remains a controlled substance outside those routes.
Can my GP prescribe medical cannabis in Denmark?
A GP may prescribe scheme products, particularly for pain, because Danish doctors have free prescribing rights. The guideline recommends a neurologist for MS and spinal cord injury and a cancer or palliative specialist for chemotherapy nausea. No doctor is obliged to prescribe, and Sativex and Epidyolex need a specialist.
Is medical cannabis subsidised in Denmark?
Yes. The region pays 50% of the first 20,000 DKK a patient spends on scheme products in a 12-month period, and nothing above that. Patients with a terminal-care permit receive full coverage. The minister can adjust these limits twice a year.
Is Sativex available in Denmark?
Yes. Sativex is one of two authorised cannabis-based medicines in Denmark, alongside Epidyolex. Only specialist doctors can prescribe either one, and both sit outside the cannabis scheme.
Can I bring my medical cannabis into Denmark?
The agency allows medicine with euphoriant substances to enter in up to 30 days’ supply for personal use, with proof of prescription, and never by post. Its pages do not promise that a specific foreign product will be accepted. Check the agency’s current import rules before you travel.
Sources
- Lægemiddelstyrelsen (Danish Medicines Agency). Medicinsk cannabis. Updated 3 June 2026.
- Lægemiddelstyrelsen. Ordningen med medicinsk cannabis. Updated 1 January 2026.
- Lægemiddelstyrelsen. Vejledning om lægers behandling af patienter med medicinsk cannabis, VEJ nr 9750 af 14/08/2026.
- Folketinget. Lov nr 439 af 06/05/2025.
- Indenrigs- og Sundhedsministeriet. Lovforslag L 135 (2024-25).
- Indenrigs- og Sundhedsministeriet. Bekendtgørelse om tilskud til cannabisslutprodukter, BEK nr 1586 af 05/12/2025.
- Lægemiddelstyrelsen. Medicintilskudsgrænser. Updated 2 March 2026.
- Indenrigs- og Sundhedsministeriet. Ny aftale: Ordning med medicinsk cannabis på recept bliver permanent. 28 November 2024.
- Lægemiddelstyrelsen. Are you importing medicine containing doping or euphoriant substances? Updated 30 April 2026.
- Lægemiddelstyrelsen. New rules for personal import of medicines to Denmark as of 1 January 2026. 11 December 2025.
- Hjorthøj C, La Cour P, Nordentoft M, Posselt CM. Cannabis-based medicines and medical cannabis for patients with neuropathic pain and other pain disorders. Eur J Pain. 2022. doi:10.1002/ejp.1874
- Kudahl B, Berg ME, Posselt CM, Nordentoft M, et al. Medical cannabis and cannabis-based medicine show both potential efficacy and potential harms. Complement Ther Clin Pract. 2021. doi:10.1016/j.ctcp.2021.101476
- Horsted T, Hesthaven KL, Leutscher PDC. Safety and effectiveness of cannabinoids to Danish patients with treatment refractory chronic pain. Eur J Pain. 2023. doi:10.1002/ejp.2054
- Holt A, Nouhravesh N, Strange JE, Kinnberg Nielsen S, et al. Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study. Eur Heart J. 2024. doi:10.1093/eurheartj/ehad834
- Rosenbæk F, Riisgaard H, Nielsen JB, Wehberg S, et al. GPs’ prescription patterns, experience, and attitudes towards medicinal cannabis. BMC Prim Care. 2023. doi:10.1186/s12875-023-01971-4